NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

抗精神病藥的全球市場:各級,各用途-至2025年的世界預測-COVID-19累積的影響

Antipsychotic Drugs Market Research Report by Class, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 995407
出版日期 內容資訊 英文 194 Pages
商品交期: 最快1-2個工作天內
價格
抗精神病藥的全球市場:各級,各用途-至2025年的世界預測-COVID-19累積的影響 Antipsychotic Drugs Market Research Report by Class, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 194 Pages
簡介

全球抗精神病藥的市場規模,預計從2020年的77億2988萬美元,至2025年末成長為108億3586萬美元。

COVID-19是影響幾乎全部產業的無與倫比的世界公共衛生緊急事件,在預測期間內預計帶給產業的成長長期性的影響。目前進行的調查擴大了框架,以確保包括潛在的COVID-19問題和發展途徑。 本報告提供有關COVID-19的見解,其中考慮了消費者行為和需求的變化,購買方式,供應鏈的新路由,當前市場力量的動態以及政府的重要介入等COVID-19對市場的影響相關洞察。更新的調查,考慮市場上COVID-19的影響,提供洞察,分析,估計,及預測。

本報告提供抗精神病藥市場調查,市場概要,市場成長要素及阻礙因素分析,各級、各用途、各地區的市場規模的變化與預測,COVID-19累積的影響,競爭情形,主要企業的簡介,市場機會等全面性資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查對象年份
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 製作計劃:調查計劃
    • 實施實行:調查
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 市場預測
  • 各用途預測
  • 各級預測
  • 各地區的預測
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特五力分析
    • 新加入業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 各級的全球抗精神病藥市場

  • 第一代
    • Haldo
    • Navane
  • 第二世代
    • Geodon
    • Invega
    • Latuda
    • Risperdal
    • Seroquel
    • Zyprexa
  • 第三代
    • Abilify

第7章 各用途的全球抗精神病藥市場

  • 躁鬱症
  • 失智症
  • 思覺失調症
  • 單極憂鬱症

第8章 南北美洲的抗精神病藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區的抗精神病藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲、中東、非洲的抗精神病藥市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第12章 企業的實用性簡介

  • Alkermes PLC
  • Allergan PLC
  • AMBOSS GmbH
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Co. Ltd.
  • Dr. Reddy's Laboratories, Ltd.
  • Eli Lilly & Co.
  • F.Hoffmann-La Roche AG
  • Flagship Biotech International Pvt. Ltd
  • GlaxoSmithKline PLC
  • H. Lundbeck A/S
  • Karger AG
  • Luye Pharma Group
  • Merck & Co., Inc.
  • Novartis AG
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer, Inc.
  • Questex LLC
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Teva Pharmaceutical Industries, Ltd.
  • The Medicines Co.
  • Vanda Pharmaceuticals Inc.

第13章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-AD36CD897CF3

The Global Antipsychotic Drugs Market size was estimated at USD 7,729.88 Million in 2020 and expected to reach USD 8,308.75 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.82% to reach USD 12,149.03 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Antipsychotic Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Class, the Antipsychotic Drugs Market was studied across First Generation, Second Generation, and Third generation. The First Generation is further studied across Haldo and Navane. The Second Generation is further studied across Geodon, Invega, Latuda, Risperdal, Seroquel, and Zyprexa. The Third generation is further studied across Abilify.

Based on Application, the Antipsychotic Drugs Market was studied across Bipolar disorders, Dementia, Schizophrenia, and Unipolar Depression.

Based on Geography, the Antipsychotic Drugs Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Antipsychotic Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Antipsychotic Drugs Market, including Alkermes PLC, Allergan PLC, AMBOSS GmbH, AstraZeneca PLC, Bristol-Myers Squibb Company, Daiichi Sankyo Co. Ltd., Dr. Reddy's Laboratories, Ltd., Eli Lilly & Co., F.Hoffmann-La Roche AG, Flagship Biotech International Pvt. Ltd, GlaxoSmithKline PLC, H. Lundbeck A/S, Karger AG, Luye Pharma Group, Merck & Co., Inc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Pfizer, Inc., Questex LLC, Sumitomo Dainippon Pharma Co., Ltd., Teva Pharmaceutical Industries, Ltd., The Medicines Co., and Vanda Pharmaceuticals Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Antipsychotic Drugs Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antipsychotic Drugs Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antipsychotic Drugs Market?
  • 4. What is the competitive strategic window for opportunities in the Global Antipsychotic Drugs Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Antipsychotic Drugs Market?
  • 6. What is the market share of the leading vendors in the Global Antipsychotic Drugs Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Antipsychotic Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Application Outlook
  • 3.4. Class Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of psychosis and associated diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Patent expiry of established brands
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing prevalence of psychosis and associated diseases
      • 5.1.3.2. Enhancement in healthcare facilities coupled with government efforts to improve healthcare sector
    • 5.1.4. Challenges
      • 5.1.4.1. Negative impact on the patients such as insomnia, blurred vision, and dry mouth
      • 5.1.4.2. Stringent regulatory framework and compliance
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Antipsychotic Drugs Market, by Class

  • 6.1. Introduction
  • 6.2. First Generation
    • 6.2.1. Haldo
    • 6.2.2. Navane
  • 6.3. Second Generation
    • 6.3.1. Geodon
    • 6.3.2. Invega
    • 6.3.3. Latuda
    • 6.3.4. Risperdal
    • 6.3.5. Seroquel
    • 6.3.6. Zyprexa
  • 6.4. Third generation
    • 6.4.1. Abilify

7. Antipsychotic Drugs Market, by Application

  • 7.1. Introduction
  • 7.2. Bipolar disorders
  • 7.3. Dementia
  • 7.4. Schizophrenia
  • 7.5. Unipolar Depression

8. Americas Antipsychotic Drugs Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Antipsychotic Drugs Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Antipsychotic Drugs Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Alkermes PLC
  • 12.2. Allergan PLC
  • 12.3. AMBOSS GmbH
  • 12.4. AstraZeneca PLC
  • 12.5. Bristol-Myers Squibb Company
  • 12.6. Daiichi Sankyo Co. Ltd.
  • 12.7. Dr. Reddy's Laboratories, Ltd.
  • 12.8. Eli Lilly & Co.
  • 12.9. F.Hoffmann-La Roche AG
  • 12.10. Flagship Biotech International Pvt. Ltd
  • 12.11. GlaxoSmithKline PLC
  • 12.12. H. Lundbeck A/S
  • 12.13. Karger AG
  • 12.14. Luye Pharma Group
  • 12.15. Merck & Co., Inc.
  • 12.16. Novartis AG
  • 12.17. Otsuka Pharmaceutical Co. Ltd.
  • 12.18. Pfizer, Inc.
  • 12.19. Questex LLC
  • 12.20. Sumitomo Dainippon Pharma Co., Ltd.
  • 12.21. Teva Pharmaceutical Industries, Ltd.
  • 12.22. The Medicines Co.
  • 12.23. Vanda Pharmaceuticals Inc.

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2026
  • FIGURE 10. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY HALDO, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY HALDO, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY NAVANE, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY NAVANE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEODON, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEODON, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INVEGA, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INVEGA, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY LATUDA, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY LATUDA, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY RISPERDAL, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY RISPERDAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SEROQUEL, 2018-2026 (USD MILLION)
  • FIGURE 27. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SEROQUEL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ZYPREXA, 2018-2026 (USD MILLION)
  • FIGURE 29. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ZYPREXA, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 30. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2026 (USD MILLION)
  • FIGURE 31. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 32. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ABILIFY, 2018-2026 (USD MILLION)
  • FIGURE 33. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ABILIFY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 34. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 35. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 37. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY BIPOLAR DISORDERS, 2018-2026 (USD MILLION)
  • FIGURE 38. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY BIPOLAR DISORDERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 39. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY DEMENTIA, 2018-2026 (USD MILLION)
  • FIGURE 40. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY DEMENTIA, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 41. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SCHIZOPHRENIA, 2018-2026 (USD MILLION)
  • FIGURE 42. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SCHIZOPHRENIA, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 43. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY UNIPOLAR DEPRESSION, 2018-2026 (USD MILLION)
  • FIGURE 44. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY UNIPOLAR DEPRESSION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 45. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 46. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 48. ARGENTINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. BRAZIL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. CANADA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. MEXICO ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. CALIFORNIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. FLORIDA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. ILLINOIS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. NEW YORK ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. OHIO ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. PENNSYLVANIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. TEXAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 61. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 63. CHINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. INDIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. INDONESIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. JAPAN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. MALAYSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. PHILIPPINES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. SOUTH KOREA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. THAILAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 72. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 73. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 74. FRANCE ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. GERMANY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 76. ITALY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 77. NETHERLANDS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 78. QATAR ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 79. RUSSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 80. SAUDI ARABIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 81. SOUTH AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 82. SPAIN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 83. UNITED ARAB EMIRATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 84. UNITED KINGDOM ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 85. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 86. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 87. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 88. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTIPSYCHOTIC DRUGS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY HALDO, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY NAVANE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEODON, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INVEGA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY LATUDA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY RISPERDAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SEROQUEL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ZYPREXA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ABILIFY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY BIPOLAR DISORDERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY DEMENTIA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SCHIZOPHRENIA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY UNIPOLAR DEPRESSION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. ARGENTINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. ARGENTINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. BRAZIL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. BRAZIL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. CANADA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. CANADA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. MEXICO ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. MEXICO ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. CALIFORNIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. CALIFORNIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. FLORIDA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. FLORIDA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. ILLINOIS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. ILLINOIS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. NEW YORK ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. NEW YORK ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. OHIO ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. OHIO ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. PENNSYLVANIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. PENNSYLVANIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. TEXAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. TEXAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. CHINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. CHINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. INDIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. INDIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. INDONESIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. INDONESIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. JAPAN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. JAPAN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. MALAYSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. MALAYSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. PHILIPPINES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. PHILIPPINES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. SOUTH KOREA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. SOUTH KOREA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. THAILAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. THAILAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. FRANCE ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. FRANCE ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. GERMANY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. GERMANY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. ITALY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. ITALY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. NETHERLANDS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. NETHERLANDS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. QATAR ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. QATAR ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. RUSSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. RUSSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. SAUDI ARABIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. SAUDI ARABIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. SOUTH AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. SOUTH AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. SPAIN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. SPAIN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. UNITED ARAB EMIRATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. UNITED ARAB EMIRATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. UNITED KINGDOM ANTIPSYCHOTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. UNITED KINGDOM ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: SCORES
  • TABLE 94. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: BUSINESS STRATEGY
  • TABLE 95. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: PRODUCT SATISFACTION
  • TABLE 96. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: RANKING
  • TABLE 97. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 98. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 99. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: MERGER & ACQUISITION
  • TABLE 100. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 101. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 102. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: INVESTMENT & FUNDING
  • TABLE 103. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 104. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: LICENSE & PRICING
  • TABLE 105. GLOBAL ANTIPSYCHOTIC DRUGS MARKET: CONTACT DETAILS